Tomorrow | ASH Research Collaborative 's Session on Accelerating Research and Collaborative Clinical Care through RWE. Prof Hernandez Rivas will be part of the panel to highlight the work of the HARMONY Alliance 🗓️Saturday, Dec 7 ⏰4:00 - 5:30 PM 📍Pacific Ballroom Salons 24-26,

Pop by poster 2226 this evening to discover the MM Risk Calculator developed by Adrián Mosquera Orgueira and his team. The tool provides individualized risk predictions for newly diagnosed MM patients using machine learning models #bigdataforbloodcancers #ASH2024 EMN

Always a pleasure to catch up with ⁦Adrián Mosquera Orgueira⁩ who spoke about all things AI🤖 ⭐️Smartcytoflow: a machine learning decision support system ⭐️Novel machine learning-based risk scores for multiple myeloma ⭐️Automated image analysis of DLBCL histological slides

Tomorrow 7:30 am. The HARMONY Alliance is having a session at ELN Breakfast Meeting at the Liberty Station Conference Center. Join us to discover latest results from our Big Data Platform! Link to full program of the session bit.ly/4gpHQ5z #ASH2024

Tomorrow | Mark your schedule for Dr Elias K. Mai MD ‘s oral presentation. Can’t wait to see the results of his study on Early Relapse in 10843 Patients with Newly-Diagnosed MM, a collaborative effort of EMN on HARMONY Big Data Platform 🗓️Monday December 9 ⏰3:30 pm

Don't miss Dr Rabea Mecklenbrauck’s oral presentation today. She will be sharing the results of her research on 'The Prognostic Impact of Myelodysplasia-Related Gene Mutations in AML patients with FLT3-ITD Mutations' 🗓️Monday December 9 ⏰ 3:30pm PST 📍Grand Hall C,

New #EHAUnplugged episode available now: Acute Promyelocytic Leukemia (EHA2024) Join us for an insightful talk by Prof. Maria Teresa Voso as she discusses the advances in the treatment and clinical outcomes of a rare subtype of AML, the acute promyelocytic leukemia (APL). Prof

MIRACLE is a Marie Skłodowska-Curie doctoral network that equips a new generation of researchers with the skills to advance and accelerate development of novel therapeutics directed at leukemia MRD. 10 doctoral candidates will have the chance to gain skills in advanced data

🔬 El #IISLaFe impulsa OmicSpace, una plataforma innovadora que conecta datos genómicos y clínicos de forma segura y eficiente 📍 Financiado con 4,5M€, integrará hospitales y biobancos de cinco comunidades autónomas 🔗 iislafe.es/es/sociedad/no… #SomosLaFe #OmicSpace

Throwback to last week's HARMONY Session at ELN Symposium, where our researchers presented the progress achieved in the different disease areas, and introduced advanced tools that will support the consecution of promising results and the generation of new research ideas

Deadline extended! You can still apply for the 10 PhD-candidate positions until 15 March 2015. Find the job description, more information about the 10 MIRACLE research projects and the job form at: miracle-leukemia.eu

Happy to share the latest AML manuscript within HARMONY: "Outcomes with intensive treatment for acute myeloid leukemia: an analysis of two decades of data from the HARMONY Alliance" recently published in Haematologica: haematologica.org/haematologica/… HARMONY Alliance Foundation #AMLsm

📢 Excited to share our latest publication in Haematologica ! Outcomes with intensive treatment for acute myeloid leukemia: an analysis of two decades of data from the HARMONY Platform. Read the full paper here 👉 doi.org/10.3324/haemat… A joint effort from researchers at

European Hematology Association #EHA2025 Congress starts tomorrow in #Milan. Honored and humbled to present results in #AML from our #interdisciplinary #collaborative efforts from the HARMONY Alliance Foundation project during the #plenary abstract session on Saturday at 13:00. #BigData for better outcomes

Are you attending the EHA Congress in Milan? Then, you cannot miss ComputationalHematology - Amin Turki MD/PhD presentation on Unsupervised Genomic Classification of Patients with AML Using Hierarchical Dirichlet Mixture Models #EHA2025 #hematology #ML

Abstracts presented during the plenary session of #EHA2025 spanned from novel drug regimens for #myeloma and #lymphoma to investigation of leukemias on the molecular and genetic levels. Learn more here: hubs.li/Q03s7Cqk0

The late-breaking abstracts presented on the last day of #EHA2025 show “what a vibrant clinical specialty we’re in,” according to session cochair Brian Huntly, PhD. Learn more here: hubs.li/Q03s7F6n0